iShares Biotechnology ETF (IBB) Performance

NASDAQ: IBBTotal returns, calendar years, drawdowns and risk since 2001.

IBB total return

Distributions reinvested · as of Oct 23, 2026
YTD
+23.2%
since Dec 31, 2025
1 year
+34.7%
total return
5 years
+5.8%
a year
10 years
+9.1%
a year
Since first price
+7.5%
a year since 2001

IBB trailing returns vs SPY, QQQ, AGG

IBB trailing returns
PeriodIBB total returnPrice onlyS&P 500 (SPY)Nasdaq-100 (QQQ)U.S. bonds (AGG)
1 month+0.6%+0.6%−1.0%−5.0%+0.9%
3 months+9.9%+9.9%+3.2%+1.9%−0.4%
6 months+21.1%+21.1%+7.8%+8.4%−1.5%
YTD+23.2%+23.1%+12.3%+15.1%−1.0%
1 year+34.7%+34.4%+14.4%+15.9%−1.1%
3 years+80.3%+21.7%/yr+79.1%+87.4%+23.3%/yr+101.4%+26.3%/yr+16.6%+5.2%/yr
5 years+32.8%+5.8%/yr+31.1%+79.3%+12.4%/yr+94.0%+14.2%/yr−0.8%−0.2%/yr
10 years+138.8%+9.1%/yr+132.7%+315.9%+15.3%/yr+538.9%+20.4%/yr+14.0%+1.3%/yr
15 years+563.3%+13.4%/yr+541.0%+696.0%+14.8%/yr+1,299.3%+19.2%/yr+32.2%+1.9%/yr
20 years+728.4%+11.2%/yr+693.0%+696.9%+10.9%/yr+1,839.9%+16.0%/yr+79.6%+3.0%/yr
Since inceptionFeb 9, 2001+544.3%+7.5%/yr+516.7%———

Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.

Growth of $10,000: IBB vs SPY

IBBS&P 500 (SPY)

From Feb 9, 2001: IBB grew to $64,429, SPY to $91,263.

Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.

IBB returns by calendar year

IBBSPY

18 of 24 full years positive. Best 2013 (+65.5%), worst 2002 (−45.8%). 2026 is year to date.

IBB annual returns table

IBB calendar-year returns
YearIBBLargest dropSPYQQQAGG
2026YTD+23.2%−9.6%+12.3%+15.1%−1.0%
2025+28.0%−21.2%+17.7%+20.8%+7.2%
2024−2.4%−12.1%+24.9%+25.6%+1.3%
2023+3.8%−17.9%+26.2%+54.9%+5.7%
2022−13.7%−30.5%−18.2%−32.6%−13.0%
2021+1.0%−17.5%+28.7%+27.4%−1.8%
2020+26.0%−23.6%+18.3%+48.6%+7.5%
2019+25.4%−15.3%+31.2%+39.0%+8.5%
2018−9.5%−26.6%−4.6%−0.1%+0.1%
2017+21.1%−10.5%+21.7%+32.7%+3.6%
2016−21.4%−26.1%+12.0%+7.1%+2.4%
2015+11.6%−27.3%+1.2%+9.4%+0.5%
2014+33.8%−21.2%+13.5%+19.2%+6.0%
2013+65.5%−9.8%+32.3%+36.6%−2.0%
2012+32.1%−12.8%+16.0%+18.1%+3.8%
2011+11.7%−22.7%+1.9%+3.4%+7.7%
2010+14.8%−18.9%+15.1%+19.9%+6.4%
2009+15.2%−20.7%+26.4%+54.7%+3.0%
2008−12.3%−32.9%−36.8%−41.7%+7.9%
2007+4.5%−10.5%+5.1%+19.0%+6.6%
2006+0.7%−20.5%+15.8%+7.1%+3.9%
2005+2.4%−15.4%+4.8%+1.6%+2.3%
2004+4.8%−27.3%+10.7%+10.5%+3.8%
2003+45.8%−17.3%+28.2%+49.7%—
2002−45.8%−54.5%−21.6%−37.4%—

Largest drop = deepest fall from a high within that calendar year.

Calendar-year return vs largest drop within the year

Calendar-year returnLargest drop within the year

Most years include a sizable fall at some point even when the year ends higher.

IBB largest drawdowns

Now 4.2% below the high
IBB largest drawdowns
PeakDeclineBottomRecoveredFallUnderwater
Jun 5, 2001−62.8%Jul 10, 2002Apr 27, 20111.1 years9.9 years
Aug 9, 2021−39.8%Jun 16, 2022Jan 7, 202610 months4.4 years
Jul 20, 2015−39.2%Jun 27, 2016May 11, 202011 months4.8 years
Feb 12, 2001−34.7%Apr 3, 2001May 22, 200150 days3 months
Jul 8, 2011−22.7%Aug 8, 2011Jan 10, 201231 days6 months
Feb 25, 2014−21.2%Apr 14, 2014Aug 26, 201448 days6 months

Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.

IBB risk statistics

IBB risk statistics
Statistic3 years5 years10 yearsSince 2001
Annualized return+20.1%+5.7%+8.4%+7.8%
Volatility (annualized)18.6%18.8%19.8%22.0%
Sharpe ratio0.850.200.39—
Sortino ratio1.600.300.62—
Best month+12.4%+12.4%+15.1%+19.4%
Worst month−7.5%−13.6%−14.7%−21.2%
Best 12 months+51.6%+51.6%+51.6%+79.0%
Worst 12 months−10.0%−27.5%−29.3%−48.9%
Positive months61%55%56%56%
Beta vs S&P 5000.650.690.81—
Correlation with S&P 5000.430.580.63—

From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.

IBB rolling returns

IBB rolling returns
Holding periodPeriodsWorstMedianBestPositive
1-year297−48.9%+9.7%+79.0%69%
3-year (a year)273−9.3%+6.3%+44.9%78%
5-year (a year)249−6.1%+6.2%+37.0%91%
10-year (a year)189−0.1%+12.5%+18.7%99%

Every holding period starting at a month-end since 2001. Returns for 3 years and longer are annualized.

IBB performance overview

iShares Biotechnology ETF (IBB) returned +34.7% over the past year and +9.1% a year over ten years, with distributions reinvested. Since its first recorded price in 2001 it has returned +7.5% a year, turning $10,000 into about $64,429. Over the same year S&P 500 (SPY) returned +14.4%.

The deepest decline was −62.8%, from Jun 5, 2001 to Jul 10, 2002, and it took 8.8 years to get back to the old high. IBB finished 18 of its 24 full calendar years with a gain; the best year was 2013 (+65.5%) and the worst 2002 (−45.8%). Volatility has been 22.0% a year.

Related: IBB chart, IBB holdings, IBB dividends. See the IBB overview for the latest quote and fund facts.

IBB performance FAQ

What is the IBB return over the past year?

IBB returned +34.7% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 34.4%.

What is the average annual return of IBB?

IBB has returned +5.8% a year over 5 years, +9.1% a year over 10 years, +7.5% a year since February 9, 2001 (total return, distributions reinvested).

How much would $10,000 invested in IBB be worth?

$10,000 invested in IBB at its first recorded close on February 9, 2001 would be worth about $64,429 on October 23, 2026 with distributions reinvested.

What was the worst year for IBB?

The worst calendar year was 2002, with a total return of −45.8%. The best was 2013 at +65.5%.

What is the biggest drawdown of IBB?

The largest peak-to-trough decline was −62.8% between June 5, 2001 and July 10, 2002. It recovered to the old high on April 27, 2011, 8.8 years after the bottom.

How volatile is IBB?

Over the past 3 years IBB had an annualized volatility of 18.6% and a Sharpe ratio of 0.85 (excess return over 1–3 month T-bills per unit of risk).